Chameleon Biosciences

San Anselmo, United States

Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.

Nov 2022

Seed

Biotechnology Genetics Therapeutics

Top Investors

Matrix Partners China SkyDeck Berkeley Cantos Berkeley SkyDeck Fund Tachyon Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Chameleon Biosciences

Who are Chameleon Biosciences's investors?

Chameleon Biosciences's investors include Matrix Partners China, SkyDeck Berkeley, Cantos, Berkeley SkyDeck Fund, Tachyon Ventures.

Where is Chameleon Biosciences headquartered?

Chameleon Biosciences is headquartered in San Anselmo, United States.

What does Chameleon Biosciences do?

Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.

What stage is Chameleon Biosciences at?

Chameleon Biosciences is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 1, 2022.

MLA

"Chameleon Biosciences — Funding & Investors." VCBacked, November 1, 2022, https://www.vcbacked.co/company/chameleon-biosciences. Accessed July 3, 2026.

APA

VCBacked. (2022). Chameleon Biosciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/chameleon-biosciences

Wikipedia (cite web)

{{cite web |title=Chameleon Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/chameleon-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 1, 2022.